Gilead Sciences News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

26.09.14	Gilead Gets Positive CHMP Opinion For Harvoni To Treat HCV Infection In Adults (RTTNews)
24.09.14	Gilead's HIV Tablet Regimen Meets Primary Objective In Two Phase 3 Trials (RTTNews)
19.09.14	European Commission Grants Marketing Authorization To Gilead's Zydelig (RTTNews)
17.09.14	Gilead Reports Phase 2 Trial Results Of Simtuzumab For Pancreatic Cancer (RTTNews)
16.09.14	Gilead Expands Access To Hepatitis C Drugs In Developing Countries (RTTNews)
15.09.14	Mylan Signs Deal With Gilead Sciences On Sovaldi And Ledipasvir/Sofosbuvir (RTTNews)
15.09.14	Gilead licenses hepatitis C drug to Cipla, Ranbaxy, five others (Reuters)
08.09.14	Gilead: AMBITION Study Of Ambrisentan/Tadalafil Achieves Primary Endpoint (RTTNews)
15.08.14	Roche verliert Verfahren um Hepatitis-Mittel (AWP)
15.08.14	Wall Street schliesst schwächer -- US-Anleihen: Kursgewinne -- Eskalation in Ukraine drückt SMI ins Minus -- Dax bricht Erholung ab -- Europäische Börsen schliessen im Minus (finanzen.ch)
06.08.14	Kassen befürchten Milliardenkosten durch neues Hepatitis-Medikament (dpa-afx)
25.07.14	Gilead Sciences Gets Positive CHMP Opinion For Zydelig - Quick Facts (RTTNews)
12.07.14	U.S. Senators Ask Gilead To Explain Solvaldi Pricing (RTTNews)
16.06.14	Gilead: Japan Phase 3 Trial For Ledipasvir/Sofosbuvir Combination Met Main Goal (RTTNews)
03.06.14	Gilead Reports Interim Phase 2 Results For GS-9973 - Quick Facts (RTTNews)
10.05.14	Gilead:Study Shows Reduction In AFB With Combination Of Ranolazine & Dronedarone (RTTNews)
09.05.14	Gilead Announces Phase 1 Data For GS-6615 In Patients With Long QT-3 Syndrome (RTTNews)
08.05.14	Gilead Announces New $5 Bln Stock Buyback Program (RTTNews)
23.04.14	Gilead Sciences Q1 Profit More Than Triples, Results Beat View (RTTNews)
23.04.14	After-market Movers For April 22 (T, AMGN, YUM, GILD, SWKS, SMCI, ILMN, SKX, CREE, ISRG) (RTTNews)
23.04.14	Gilead Sciences Q1 Profit Rises; Reiterates 2014 Guidance (RTTNews)
22.04.14	Earnings Watch For April 22 (MCD, JNPR, UTX, TRV, AMGN, T, XRX) (RTTNews)
22.04.14	LLY Adds New Drug To Portfolio, GILD Faces FDA Decision, IMUC Catches Eyes (RTTNews)
21.04.14	FDA Accepts Gilead's NDAs For Cobicistat And Elvitegravir For HIV Therapy (RTTNews)
17.04.14	Gilead Sciences, Inc. Feeling Sovaldi Pressure From All Sides (MotleyFool)
14.04.14	Bristol-Myers Submits NDA For Combination Tablet Of Atazanavir With Cobicistat (RTTNews)
11.04.14	Gilead's Sovaldi Shows Efficacy & Safety In Chronic Hepatitis C Patients (RTTNews)
10.04.14	Natco moves to oppose Gilead hepatitis C drug patent in India - source (Reuters)
10.04.14	Gilead's Phase 2 Trials With Sofosbuvir-Based Regimens Show Positive Results (RTTNews)
10.04.14	Gilead Sciences Reports Results From Sovaldi Trial For HCV Retreatment (RTTNews)
08.04.14	Gilead aims to license hepatitis C drug to 3-4 Indian firms (Reuters)
08.04.14	IMMU Chugs Along, MNKD Decision Delayed, QCOR Bought Out, Another First For ISR (RTTNews)
07.04.14	Moody's: Debt-financed acquisitions put healthcare companies' credit metrics at risk (Moodys)
07.04.14	Gilead: Ledipasvir/Sofosbuvir Fixed-Dose Combination Granted FDA Priority Review (RTTNews)
03.04.14	Moody's: Pharmaceutical companies to benefit from new blood cancer drugs (Moodys)
03.04.14	CRY Has Reason To Smile, GILD Eyes Japan, ROSG Inks Deal, OxySure Breathes Easy (RTTNews)
27.03.14	EMA Validates Gilead's Marketing Application For LDV/SOF Combination (RTTNews)
14.03.14	Idenix Files Patent Infringement Lawsuits Against Gilead Sciences In Europe (RTTNews)
04.03.14	Gilead Sciences, Inc. -- Moody's rates Gilead's notes Baa1; positive outlook (Moodys)
06.02.14	Gilead to license hepatitis C drug to lower-cost manufacturers in India (Reuters)
04.02.14	Gilead Profit Tops Estimates (RTTNews)
04.02.14	Gilead Sciences Q4 Profit Up - Quick Facts (RTTNews)
04.02.14	Earnings Watch For February 4 (BIDU, GILD, UNM, BSX, CLX) (RTTNews)
30.01.14	DEPO Prevails In Markman Hearing, IDIX, KBIO Get Smacked, ONVO Ahead Of Target (RTTNews)
17.01.14	Gilead: European Commission Grants Marketing Authorization For Sovaldi (RTTNews)
13.01.14	Gilead Sciences: FDA Accepts NDA For Idelalisib For Treatment Of Refractory INHL (RTTNews)
19.12.13	ALIM, PSDV Rally After Iluvien News, GILD Lays Out Plan, REGN Gets FDA Date (RTTNews)
18.12.13	Gilead Reports Topline Results From Phase 3 Study Of ION-1, ION-2 And ION-3 (RTTNews)
16.12.13	Health Canada Issues Notice Of Compliance To Gilead Sciences For Sovaldi (RTTNews)
13.12.13	Gilead Sciences Gets FDA Approval For HIV-1 Regimen Complera - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten
20.12.24		SPI-Handel aktuell: SPI zum Handelsende leichter
20.12.24		Handel in Europa: STOXX 50 schliesst im Minus

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

Schwacher Handel: SMI schliesst mit Verlusten

20.12.24

SPI-Handel aktuell: SPI zum Handelsende leichter

20.12.24

Handel in Europa: STOXX 50 schliesst im Minus